Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand
of the new medicine set out in the Schedule hereto:
Schedule
Product: Daivobet
Active Ingredients: Betamethasone dipropionate 643µg/g equivalent to 500µg/g betamethasone
Calcipotriol 50µg/g
Dosage Form: Topical ointment
New Zealand Sponsor: CSL New Zealand Limited
Manufacturer: Leo Laboratories Limited, Crumlin, Dublin, Eire
Dated this 14th day of April 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).